Department of Health written question – answered at on 4 January 2016.
To ask Her Majesty’s Government what evaluation they have carried out of the potential cost savings from centralised procurement of common generic drugs in the light of evidence from other countries using high volume contracts.
On behalf of National Health Service secondary care establishments (hospitals) in England the Department’s Commercial Medicines Unit undertakes a long established centralised tender programme for framework agreements for generic medicines. This is in compliance with European Union procurement regulations.
Yes0 people think so
No2 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.